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INTRODUCTION
The veterinarian's primary role involves 
the use of scientific knowledge and skills 
for the protection of animal health and the 
relief of animal suffering. Scientific 
knowledge in this sense would include the 
r a n g e  o f  a p p r o a c h e s  f r o m  m e r e 
observation of signs to the use of 
sophisticated methods available for the 
management and treatment of animal 
ailments. The information gained from 
serum biochemistry, for example, would 
substantiate physical  examination 
coupled with medical history to provide 
excellent basis for judgment with respect 
to the nature of the disease, the extent of 
tissue and organ damage and selection of 
appropriate treatment (Schalm et al., 
1975).  The Critically-ill patient describes 
those with diseases  that  are  l i fe-
threatening such that they need constant 
monitoring and usually have secondary 
involvement of a number of organ 
systems, regardless of the primary organ 
dysfunction, and therefore require total 
body care (Burrows, 1981).
The average Nigerian veterinarian has 
long relied largely on mere observation of 
signs and physical examination of patients 
in coming up with a diagnosis of disease or 
the prediction of the chances of survival of 
his patients and the formulation of 
appropriate therapeutic strategies. The 
result is that many patients are lost to 
practice that is merely based on what can 
be physically seen, while less attention is 
paid to determining the underlying 
aetiology. Also lost is the professional and 
moral dignity of the veterinarian as clients 
would tend to question the clinical 
competence of the doctor. While economic 
considerations hinder, to a large extent, the 
application of standard laboratory 
evidence to veterinary practice in Nigeria, 
it is important to understand that best 
practices need to be embraced in order to 
bring the Nigerian veterinary practice in 
consonance with what obtains in the rest of 
the world.
This paper attempts to evaluate the current 
contribution of biochemical markers in the 
management of veterinary patients, and 
especially the critically-ill patient. Most, if 
not all, diseases are manifestations of 
abnormalities of molecules, chemical 
reactions or biochemical processes. 
Biochemical tests are performed for four 
main reasons: diagnosis, monitoring, 
prognosis and screening. When used 
appropriately, biochemical tests can 
contribute substantially to the overall care 
of the patient. The critically-ill patient is 
especially implicated for the use of clinical 
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biochemistry tools as valuable information 
c a n  b e  o b t a i n e d  f r o m  m e a s u r e d 
parameters that can offer advantage in 
prediction of the outcome of diseases. 
Despite the observed importance of clinical 
chemistry and laboratory medicine in 
clinical medicine, the attitude of Nigerian 
veterinarians in practice towards the use of 
laboratory tests appear to be very minimal, 
or even non-existent in some cases. In 
keeping with contemporary global best 
practices, practicing veterinarians in 
Nigeria  must  seek to  employ this 
invaluable tool. It is hoped that this paper 
will create the needed awareness among 
Nigerian veterinarians in employing 
clinical biochemistry in the management of 
patients, towards improving veterinary 
practice in the country. Keywords: Clinical 
biochemistry, Nigeria, Veterinarian, 
critically-ill patient
What is Clinical Biochemistry?
Clinical Biochemistry refers to that branch 
of laboratory medicine in which chemical 
and biochemical methods are applied to 
the study of disease (Gaw et al, 1999). In 
t h e o r y ,  t h i s  e m b r a c e s  a l l  n o n -
morphological studies, but in practice, it is 
usually, though not exclusively, confined to 
studies on blood and urine, although 
analyses are made on other body fluids 
(Gaw, et al, 1999). Clinical biochemistry 
can be a useful aid to the veterinary 
practitioner for the diagnosis of disease, 
and is one of a number of laboratory 
investigations which are employed 
(Douglass and Eckersall, 1985).
Biochemical investigations are involved, to 
varying degrees, in every branch of clinical 
medicine. The results of biochemical tests 
may be of use in diagnosis and in 
monitoring of treatment. Biochemical tests 
may also be of value in screening for 
disease or in assessing the prognosis, once 
a  d i a g n o s i s  h a s  b e e n  m a d e .  T h e 
biochemistry laboratory is often involved 
in research into the biochemical basis of 
disease and in clinical trials of new drugs. 
Clinical biochemistry provides a variety of 
non-invasive tools that can be used as 
prognostic markers for the management of 
animal patients. The repertoire of common 
t e s t s  c a r r i e d  o u t  i n  t h e  c l i n i c a l 
biochemistry laboratory is presented in 
Table I.
Information from clinical test results will 
be of value only if it is accurate and 
relevant,  and if  i ts  significance is 
appreciated by the clinician so that it can be 
used appropriately to guide clinical 
d e c i s i o n - m a k i n g .  T h e  s u c c e s s  o f 
biochemical tests depends on appropriate 
sample collection and analysis and the 
monitoring of factors that can influence 
biochemical variables. Such factors 
include age, sex, stress, nutritional status, 
drugs etc. (Brommer et al, 2001) Errors 
that affect the results of biochemical tests 
may be pre-analytical (e.g. patient/sample 
misidentification; inappropriate test 
Table I: The Clinical Biochemistry repertoire  
Core biochemical 
tests 

















































Source:  Gaw et al. (1999) Clinical Biochemistry: An 
illustrated color text. 2nd edition
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request; errors in sample collection; 
inappropriate container, handling, storage 
and transportation), analytical (e.g. 
equipment malfunction, sample mix-ups, 
undetected failure in quality control) or 
post-analytical (e.g. improper data entry, 
erroneous validation of analytical data). 
Errors, can however, be minimized by 
scrupulous adherence to robust, agreed 
protocols at every stage of the testing 
process: this means a lot more than 
ensuring that the analysis is performed 
correctly.
R e f e r e n c e  r a n g e s  i n  C l i n i c a l 
Biochemistry
Biochemical test results are usually 
compared to a reference range considered 
to represent the normal healthy state. Most 
reference ranges are usually chosen to 
include 95% of the values found in healthy 
volunteers, and hence, by definition, 5% of 
the population will have a result out of the 
reference range (Bangert et al, 2008; 
Malati, 2009). In practice there are no rigid 
l i m i t s  d e m a r c a t i n g  t h e  d i s e a s e d 
population from the healthy; however, the 
further a result is from the limits of the 
range, the more likely it is to represent 
pathology. In some situations it is useful to 
define 'action limits', where appropriate 
intervention should be made in response to 
a biochemical result. It is important to 
note, however, that a test result within the 
reference range does not necessarily imply 
that there is no disease and a test result 
outside the reference range does not 
indicate disease. Also, the ranges found in 
healthy individuals from different breeds 
vary for some analytes. Since, biochemical 
variables can be influenced by intrinsic 
factors such as the breed of the animal, it is 
important that reference ranges be defined 
for specific localities (Brommer et al, 
2001).  International guidelines (e.g. by 
International Federation of Clinical 
Chemistry (IFCC) and International 
Council for Standardization in Hematology 
(ICSH), the Clinical Laboratory Standard 
Institute (CLSI) formerly known as 
N a t i o n a l  C o m m i t t e e  f o r  C l i n i c a l 
L a b o r a t o r y  S t a n d a r d s  ( N C C L S ) 
recommend that every country must 
establish reference intervals for healthy 
individuals belonging to a group of 
h o m o g e n e o u s  p o p u l a t i o n .  I t  i s 
disheartening to note that as at today, none 
of the veterinary teaching hospitals in all 
the veterinary schools in Nigeria has 
laboratory reference values as obtained in 
other parts of the world. Interpretation of 
biochemical abnormalities has largely 
been based on values obtained from 
different geographic zones.
The Critically-ill patient
The critically-ill patient represents a wide 
spectrum of disease. They include some 
trauma patients, animals undergoing 
cancer chemotherapy, animals with severe 
respiratory diseases, neurologic disease, 
pyometra, etc. The underlying feature is 
that the diseases are life-threatening so 
that they need constant monitoring and 
usually have secondary involvement of a 
number of organ systems, regardless of the 
primary organ dysfunction, and therefore 
require total body care (Burrows, 1981).
Critically-ill  patients share several 
common features, particularly the need for 
d i l igent  moni tor ing  and  nurs ing . 
Critically-ill patients have fluid, acid-base 
and electrolyte disturbances, increased 
caloric requirements and an increased 
susceptibility to infection (Burrows, 1981).
Certain patients may present with 
conditions that require predominantly 
either medical treatments or surgical 
interventions. However, a surgical 
condition,
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Table II: Physical status classification 
Classification Results of physical 
examination findings 




I Healthy, no underlying disease No abnormalities Excellent 
II Geriatric or obese animals. 
Neonates, local disease with 
mild systemic disturbance
 






Diseases with moderate 
systemic signs
 
Anaemia, cachexia. Fever, 






Disease with severe systemic 
signs
 Shock, uremia, toxaemia, 














for example, may simultaneously be 
combined with diseases that require a 
more medical intervention. In both 
situations,  a critical  evaluation of 
necessary laboratory parameters is vital in 
formulating appropriate intervention 
(surgical or medical) and in reaching a 
correct prediction of the outcome of 
intervention.
Table II presents features of physical status 
classification of veterinary patients 
(Williams and Owens, 2011). Critically-ill 
veterinary patients are/include those that 
are classified as having physical status IV 
and V, including patients suffering from 
diseases with severe systemic signs and 
patients that are moribund or comatose, 
respectively. 
Patients with physical status I – III would 
generally present fewer complications for 
management of their conditions. For 
p a t i e n t s  i n  c l a s s e s  I I  t o  V ,  i t  i s 
recommended that laboratory tests 
including total plasma protein levels, 
urinalysis and a complete chemistry profile 
be obtained as part of pre-surgical 
screening to assess the surgical risk. 
Diseases that involve a major organ system 
or more than one organ system increase 
surgical risk. These include patients with 
major cardiopulmonary abnormalities, 
renal failure, traumatic bladder rupture 
urethral obstructions, liver disease, 
endocrine disorders, diabetes mellitus, etc. 
The management of patients with physical 
status IV and V would ideally involve 
examination of a wide range of biochemical 
parameters in order to effectively manage 
their condition. Such patients present as 
poor surgical risks, and should therefore 
u n d e r g o  e x t e n s i v e  p r e - s u r g i c a l 
assessment/screening if they would 
survive surgery.
Veter inary  intensive  care  may be 
considered as too expensive for most 
practitioners, considering the involvement 
of sophisticated monitoring equipment. 
Nevertheless, it has developed into the 
round-the-clock care of the critically-ill 
patient, with constant monitoring of 
physical and laboratory parameters, 
attendance to patient's changing needs and 
support of physiological and metabolic 
functions (Burrows, 1981).
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Molecular biology tools in clinical 
biochemistry
Molecular diagnostic tools and detection 
methods such as nucleic acid amplification 
are becoming invaluable additions to 
laboratory testing and clinical evaluation, 
providing, diagnostic, therapeutic and 
prognostic information. According to 
Murray et al (2000), all diseases have 
genetic bases. Gene identification may 
provide an indication of the biochemical 
basis to the disease, thus enabling 
therapies to be designed (Brown, 1998). 
During the last few years, a number of 
genes responsible for inherited diseases 
have been identified. Once a gene 
associated with a single gene disorder has 
been isolated and cloned, it is usually easy 
to develop a gene-based diagnostic test. 
This can be used to confirm the diagnosis of 
an existing condition, as a prognostic 
indicator that an individual animal will 
eventually develop a disease, or may be at 
increased risk of developing disease 
conditions or to reveal information on a 
healthy individual animal's carrier status 
(Soetan and Salako, 2010). Genetics has 
been used in the diagnosis of mutations in 
animal diseases including:
1. Cittrullinemia in cattle (Hauge, 
1989)
2. Marple syrup urine disease (MSUD) 
in bovine (Hauge, 1989)
3. Hyperkalemic periodic paralysis 
(HYPP) in Quarter Horses, a genetic 
disease observed among quarter horses 
(Hauge, 1989).
4. Leukocyte adhesion deficiency in 
Cattle and malignant hyperthermia in pigs.
It is important to note that diagnostic 
molecular biology is widely used in a 
number of areas including haematology, 
immunology and microbiology with 
possibly the least developed area being 
clinical biochemistry. However, molecular 
methods will be increasingly incorporated 
into all areas of pathology, not to replace 
current tests but as an aid in evaluating the 
future risk of disease.
Collection of Baseline data for 
Biochemical parameters
Reference ranges are sets of values used by 
a health professional to interpret a set of 
health professional to interpret a set of 
medical test results from samples obtained 
from patients.  A reference range is usually 
defined as the set of values 95 percent of the 
normal population falls within (that is, 
95% prediction interval) (Bangert et al, 
2008). It is determined by collecting data 
from vast numbers of laboratory tests. 
Factors such as nutrition, age, sex, breed 
and cl imate were known to affect 
b i o c h e m i c a l  a n d  h e m a t o l o g i c a l 
parameters of clinically healthy dog (Coles, 
1986;  Awah and Nott idge ,  1998) . 
Variations have been observed in these 
indices between temperate and tropical 
animals (Awah and Nottidge, 1998). 
Baseline values established for animal 
breeds originating from the temperate 
regions may not be appropriate for use in 
breeds from the tropical regions. These 
variations had been thought to be due to 
the effect of nutrition, climate and sub 
clinical diseases (Ogunsanmi et al., 1999; 
Awah and Nottidge, 1998). Although 
clinical biochemistry is potentially a 
valuable diagnostic aid in the veterinary 
care of animals, the interpretation of 
results in sick animals is often difficult. Any 
physiologic and pathological changes can 
be evaluated only if the normal values are 
available for comparison. Considerable 
information is available on the normal 
biochemical test values of domestic 
animals of exotic breeds kept under 
different environment and management 
conditions. It is therefore pertinent that 
baseline values for animals kept under 
tropical  conditions be sought and 
established. This is because the use of 
biochemical values that are derived from 
exotic breeds for monitoring the health 
status of indigenous breeds could be 
misleading. 
874
ISSN 0331 - 3026Akinrinmade, J.F. and Akinrinde, A.S.
CONCLUSION
Clinical biochemistry is a potentially 
valuable aid in the management of the 
veterinary patient. Its use in veterinary 
care will, to a large extent, improve the 
capability of veterinarians to protect 
animal health and relieve suffering, 
especially in the critically-ill patient. When 
combined with physical examination and 
medical history, it can provide an excellent 
basis for decision-making in the care of 
patients.  It therefore becomes highly 
imperative for veterinarians in the 21st 
century to seek to employ this invaluable 
tool in the management of patients. 
Correct interpretation of biochemical test 
results, however, relies on the availability 
of reference ranges that are specific for 
breeds and climatic regions. In this 
respect, it would be highly beneficial for 
Veterinary teaching hospitals in the 
country  to  v igorous ly  pursue  the 
establishment of reference ranges for 
predominant breeds of domesticated 
animals domiciled in their respective 
catchment regions.
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